Distinguishing health-related parameters between metabolically healthy and metabolically unhealthy obesity in women

Parnell JQ. Definition, classification, and epidemiology of obesity.end text [Internet]. 2023; https://www.ncbi.nlm.nih.gov/books/NBK279167/.

Kinlen D, Cody D, O'Shea D. Complications of obesity. QJM. 2018;111:437–443.

Article CAS PubMed Google Scholar

Blücher M. Metabolically healthy obesity. Endocr Rev. 2020;41:bnaa004.

Philips commercial. Metabolically healthy obesity: definition, determinants, and clinical implications. Rev Endocr meta tab failure. 2013;14:219–27.

Article CAS PubMed Google Scholar

Stefan N, Herring HU, Hu FB, Schulz MB. Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. Lancet Diabetes Endocrinology. 2013;1:152–62.

Article PubMed Google Scholar

Smith GI, Mittendorfer B, Klein S. Metabolically healthy obesity: facts and illusions. J Clinic Survey. 2019;129:3978–89.

Article PubMed PubMed Central Google Scholar

Mayoral LP, Andrade GM, Mayoral EP, Huerta TH, Canseco SP, Rodal-Canales FJ et al Obesity subtypes, associated biomarkers, and heterogeneity. Indian J Med Res. 2020;151:11–21.

Article CAS PubMed PubMed Central Google Scholar

Rey-Lopez JP, de Rezende LF, Pastor-Valero M, Tess BH. The prevalence of metabolically healthy obesity: a systematic review and critical appraisal of definitions used. Obes Rev. 2014;15:781–90.

Article PubMed Google Scholar

Stephen N. Causes, consequences, and treatment of metabolically unhealthy fat distribution. Lancet Diabetes Endocrinology. 2020;8:616–27.

Article PubMed Google Scholar

Stephen N, Schultz MB. Metabolic health and cardiometabolic risk clusters: Implications for prediction, prevention, and treatment. Lancet Diabetes Endocrinology. 2023;11:426–40.

Article CAS PubMed Google Scholar

Jelliff D, Jelliff E. An underrated pioneer. Ketle: Man and index. My name is J. Clin Nuttle. 1979;32:2519–21.

Article CAS PubMed Google Scholar

Ravi CJ, Radu D, Arena R, Ortega FB, Alpert MA, Kushner RF. Health promotion and obesity prevention: JACC Health Promotion Series. J Am Col Cardiol. 2018;72:1506–31.

Article PubMed Google Scholar

van Vliet-Ostaptchouk JV, Nuotio ML, Slagter SN, Doiron D, Fischer K, Foco L, et al. Prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a joint analysis of 10 large cohort studies. BMC endocrine disorders. 2014;14:9.

Article PubMed PubMed Central Google Scholar

Liu C, Wang C, Guan S, Liu H, Wu X, Zhang Z, et al. Prevalence of metabolically healthy and unhealthy obesity according to various criteria. Obes facts. 2019;12:78–90.

Article CAS PubMed PubMed Central Google Scholar

Hamer M, Bell JA, Sabia S, Batty GD, Kivimäki M. Stability of metabolically healthy obesity over 8 years: the British Longitudinal Study of Aging. Eur J Endocrinology. 2015;173:703–08.

Article CAS PubMed Google Scholar

Fanali G, Di Masi A, Trezza V, Marino M, Fasano M, Ascenzi P. Human serum albumin: from bench to bedside. Mol Asp Med. 2012;33:209–90.

Article CAS Google Scholar

Luís C, Baylina P, Soares R, Fernandes R. Biomarkers of metabolic dysfunction as predictors of early diabetes. biomolecules. 2021;11:1589.

Article PubMed PubMed Central Google Scholar

Kunutsor SK, Apekey TA, Walley J, Kain K. Ferritin levels and risk of type 2 diabetes: an updated systematic review and meta-analysis of prospective evidence. Diabetes Metab Research Rev 2013;29:308–18.

Article CAS PubMed Google Scholar

Zhang W, Zheng J, Zhang J, Li N, Yang X, Fang ZZ, et al. Association of serum amino acids with urea cycle and risk of chronic kidney disease in Chinese with type 2 diabetes. Front End Clinol (Lausanne). 2023;14:1117308.

Article PubMed Google Scholar

Kopelman P. Physiology of prolactin secretion in obesity. Int J Obes. 2000;24:S104–S108.

Article CAS Google Scholar

Tanner MJ, Hadlow NC, Wardrop R. Fluctuations in prolactin levels in women with menopausal status and menstrual cycle stage. NZJ Obstetrics and Gynecology in Australia. 2011;51:321–4.

Article PubMed Google Scholar

Turcotte AF, O'Connor S, Morin SN, Gibbs JC, Willey BM, Jean S, et al. Associations between obesity and fracture risk, bone density and bone quality in adults: a systematic review and meta-analysis. PLoS One. 2021;16:e0252487.

Article CAS PubMed PubMed Central Google Scholar

Lonardo A, Mantovani A, Lugari S, Targher G. Epidemiology and pathophysiology of the association between NAFLD and metabolically healthy or unhealthy obesity. Ann Hepator. 2020;19:359–66.

Article CAS PubMed Google Scholar

Fortmüller CA, Uehringer D, von Herring S, Shefold JC. Serum chloride levels in critical illness – the hidden story. Intensive Care Medical Examination 2018;6:10.

Article PubMed PubMed Central Google Scholar

Wahren J, Ekberg K, Johansson J, Henriksson M, Pramanik A, Johansson BL, et al. The role of C-peptide in human physiology. Am J Physiology Endocrinology Meta Tab. 2000;278:E759–E768.

Article CAS PubMed Google Scholar

Hills CE, Brunskill, New Jersey. Cellular and physiological effects of C-peptide. clinical science. 2009;116:565–74.

Article CAS Google Scholar

Rossi MCE, Nicolucci A, Pellegrini F, Comaschi M, Ceriello A, Cucinotta D, et al Obesity and changes in the urinary albumin/creatinine ratio in patients with type 2 diabetes: the DEMAND study. Nutr Metab Cardiovascular Disease 2010;20:110–16.

Article CAS PubMed Google Scholar

Du N, Peng H, Chao X, Zhang Q, Tian H, Li H. Interaction of obesity and central obesity in increasing urinary albumin-to-creatinine ratio. PLoS One. 2014;9:98926.

Article Google Scholar